Proliferative lesions with atypia include atypical ductal hyperplasia (ADH), atypical lobular
hyperplasia (ALH), and lobular carcinoma in situ (LCIS). These lesions are considered high …

Abstract Purpose of Review The aim of this review is to summarize recently published
literature addressing atypical ductal hyperplasia (ADH), lobular neoplasia (atypical lobular …

Background Biopsy-proven breast lesions such as atypical ductal hyperplasia (ADH) or
atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS) and flat epithelial atypia …

BREAST CANCER RISK Page 1 EREA ET CANCER IN HICH-RIEK PATIENTE 1055–3207/93
3000 + 20 ATYPICAL DUCTAL AND LOBULAR HYPERPLASIA AND BREAST CANCER RISK …

Since the first pathologic studies of breast cancer were undertaken in the nineteenth century,
an intraepithelial stage has been recognized in the transition from normal tissue to invasive …

Over the past several decades, the widespread adoption of mammographic screening has
had a significant impact on the incidence, diagnosis, classification, and treatment of all …

Simple Summary This retrospective study investigates histopathological outcomes, upgrade
rates, and disease-free survival (DFS) in high-risk breast lesions, including atypical ductal …

The purpose of this paper is to present background information on carcinoma in situ (CIS) of
the breast and to provide a theoretical framework for planning epidemiologic studies which …

The hormone-sensitive epithelial cells within the lobules are the major source of ductal
carcinoma in situ (DCIS) of the breast. The neoplastic cells grow, and fill and increase the …

Breast carcinoma in situ (BCIS) is the penultimate step in the progression of normal
epithelium from hyperplasia to invasive breast cancer. There are two types of BCIS: ductal …